IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma With Bronchioloalveolar Carcinoma Subtype
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e3181abeb5d
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2009
Authors
Publisher
Elsevier BV